Recent incarceration and use of a supervised injection facility in Vancouver, Canada

References

• Adamson SJ, Sellman JD. The pattern of intravenous drug use and associated criminal activity in patients on a methadone treatment waiting list. Drug and Alcohol Review 1998; 17(2)159–166
   PubMed Web of Science ®Google Scholar
• Beyrer C, Jittiwutikarn J, Teokul W, Razak MH, Suriyanon V, Srirak N, Vongchuk T, Tovanabutra S, Sripaipan T, Celentano DD. Drug use, increasing incarceration rates, and prison-associated HIV risks in Thailand. AIDS and Behavior 2003; 7(2)153–161
   PubMed Web of Science ®Google Scholar
• Binswanger IA, Stern MF, Deyo RA, Heagerty PJ, Cheadle A, Elmore JG, Koepsell TD. Release from prison–a high risk of death for former inmates. N Engl J Med 2007; 356(2)157–165
   PubMed Web of Science ®Google Scholar
• Blumstein A, Rivara FP, Rosenfeld R. The rise and decline of homicide–and why. Annual Review of Public Health 2000; 21: 505–541
   PubMed Web of Science ®Google Scholar
• Bourgois P, Martinez A, Kral A, Edlin BR, Schonberg J, Ciccarone D. Reinterpreting ethnic patterns among white and African American men who inject heroin: A social science of medicine approach. PLoS Med 2006; 3(10)e452
   PubMed Web of Science ®Google Scholar
• Bretteville-Jensen AL, Sutton M. The income-generating behaviour of injecting drug-users in Oslo. Addiction 1996; 91(1)63–79
   PubMed Web of Science ®Google Scholar
• Broadhead RS, Kerr TH, Grund JPC, Altice FL. Safer Injection Facilities in North America: Their Place in Public Policy and Health Initiatives. Journal of Drug Issues 2002, (Winter 2002)
   Web of Science ®Google Scholar
• Broadhead RS, van Hulst Y, Heckathorn DD. The impact of a needle exchange's closure. Public health reports (Washington, DC: 1974) 1999; 114(5)439–447
   PubMed Web of Science ®Google Scholar
• Bula F. Drug plan waste of resources, city told; more drug users will come here, U.S. official warns. Vancouver Sun, November 21, 2002 2002
   Google Scholar
• Calzavara LM, Burchell AN, Schlossberg J, Myers T, Escobar M, Wallace E, Major C, Strike C, Millson M. Prior opiate injection and incarceration history predict injection drug use among inmates. Addiction 2003; 98(9)1257–1265
   PubMed Web of Science ®Google Scholar
• Case P, Meehan T, Jones TS. Arrests and incarceration of injection drug users for syringe possession in Massachusetts: Implications for HIV prevention. Journal of Acquired Immune Deficiency Syndrome Human Retrovirology 1998; 18(Suppl 1)S71–75
   Google Scholar
• Cruz MF, Patra J, Fischer B, Rehm J, Kalousek K. Public opinion towards supervised injection facilities and heroin-assisted treatment in Ontario, Canada. International Journal of Drug Policy 2007; 18: 54–61
   PubMed Web of Science ®Google Scholar
• DeBeck K, Shannon K, Wood E, Li K, Montaner JS, Kerr T. Income generating activities of people who inject drugs. Drug and Alcohol Dependence 2007; 91(1)50–56
   PubMed Web of Science ®Google Scholar
• Dolan KA, Kimber J, Fry C, McDonald D, Fitzgerald J, Trautmann F. Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia. Drug and Alcohol Review 2000; 19: 337–346
   Web of Science ®Google Scholar
• Donnelly N, Snowball L. Recent trends in property and drug-related crime in Kings Cross. Government of New South Wales, SydneyAustralia 2006
   Google Scholar
• Drucker E. Insite: Canada's landmark safe injecting program at risk. Harm Reduction Journal 2006; 3: 24
   PubMedGoogle Scholar
• Dunn J, Laranjeira R. Cocaine–profiles, drug histories, and patterns of use of patients from Brazil. Substance Use & Misuse 1999; 34(11)1527–1548
   PubMed Web of Science ®Google Scholar
• Freeman K, Jones CG, Weatherburn DJ, Rutter S, Spooner CJ, Donnelly N. The impact of the Sydney Medically Supervised Injecting Centre (MSIC) on crime. Drug and Alcohol Review 2005; 24(2)173–184
   PubMed Web of Science ®Google Scholar
• Gandey A. US slams Canada over Vancouver's new drug injection site. Canadian Medical Association Journal 2003; 169(10)1063
   Web of Science ®Google Scholar
• Hedrich D. European report on drug consumption rooms. European Monitoring Centre for Drugs and Drug Addiction, Luxembourg 2004
   Google Scholar
• Kerr T, Fairbairn N, Tyndall MW, Marsh D, Li K, Montaner J, Wood E. Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug and Alcohol Dependence 2007; 87(1)39–45
   PubMed Web of Science ®Google Scholar
• Kerr T, Tyndall M, Li K, Montaner J, Wood E. Safer injection facility use and syringe sharing in injection drug users. Lancet 2005; 366(9482)316–318
   PubMed Web of Science ®Google Scholar
• Kimber J, Dolan KA, van Beek I, Hedrich D. Drug consumption facilities: An update since 2000. Drug and Alcohol Review 2003; 22: 227–233
   PubMed Web of Science ®Google Scholar
• Lee JH, Herzog TA, Meade CD, Webb MS, Brandon TH. The use of GEE for analyzing longitudinal binomial data: A primer using data from a tobacco intervention. Addictive behaviors 2007; 32(1)187–193
   PubMed Web of Science ®Google Scholar
• Lines R, Jürgens R, Betteridge G, Stôver H, Laticevschi D, Nelles J. Prison needle exchange: Lessons from a comprehensive review of internvational evidence and experience. HIV/AIDS Legal Network, MontrealCanada 2006
   Google Scholar
• Macalino GE, Vlahov D, Sanford-Colby S, Patel S, Sabin K, Salas C, Rich JD. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. American Journal of Public Health 2004; 94(7)1218–1223
   PubMed Web of Science ®Google Scholar
• McElrath K, Chitwood DD, Comerford M. Crime victimization among injection drug users. Journal of Drug Issues 1997; 27(4)771–783
   Web of Science ®Google Scholar
• Milloy M-JS, Wood E, Small D, Tyndall M, Lai C, Montaner J, Kerr T. Incarceration experiences in a cohort of active injection drug users. Drug and Alcohol Review 2008, iFirst ahead of press
   PubMed Web of Science ®Google Scholar
• Mulgrew I. Just how bad is local violence, property crime? Statistics show incidents are actually down from previous decade. Vancouver Sun, January 3, 2006 2006
   Google Scholar
• Ochoa KC, Davidson PJ, Evans JL, Hahn JA, Page-Shafer K, Moss AR. Heroin overdose among young injection drug users in San Francisco. Drug and Alcohol Dependence 2005; 80(3)297–302
   PubMed Web of Science ®Google Scholar
• Press TC. Fewer addicts shooting up in the streets since injection site opened: Police. Nanaimo Daily News, November 18, 2003 2003
   Google Scholar
• Rotily M, Weilandt C, Bird SM, Käll K, Van Haastrecht HJ, Iandolo E, Rousseau S. Surveillance of HIV infection and related risk behaviour in European prisons. A multicentre pilot study. European Journal of Public Health 2001; 11(3)243–250
   PubMed Web of Science ®Google Scholar
• Salmon A. Sydney Medically Supervised Injecting Centre: Interim Evaluation Report #2: Evaluation of community attitudes towards the Sydney MSIC. National Centre in HIV epidemiology and clinical research, SydneyAustralia 2006
   Google Scholar
• Shah NG, Galai N, Celentano DD, Vlahov D, Strathdee SA. Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988–2000. Drug and Alcohol Dependence 2006; 83(2)147–156
   PubMed Web of Science ®Google Scholar
• Small W, Kain S, Laliberté N, Schechter MT, O'Shaughnessy MV, Spittal PM. Incarceration, addiction and harm reduction: Inmates experience injecting drugs in prison. Substance Use & Misuse 2005; 40(6)831–843
   PubMed Web of Science ®Google Scholar
• Small W, Wood E, Jürgens R, Kerr T. Injection drug use, HIV/AIDS and incarceration: Evidence from the Vancouver Injection Drug Users Study. HIV/AIDS policy & law review/Canadian HIV/AIDS Legal Network 2005; 10(3)1, 5–10
   Google Scholar
• Spittal PM, Hogg RS, Li K, Craib KJ, Recsky M, Johnston C, Montaner JS, Schechter MT, Wood E. Drastic elevations in mortality among female injection drug users in a Canadian setting. AIDS Care 2006; 18(2)101–108
   PubMed Web of Science ®Google Scholar
• Strang J, Gossop M, Heuston J, Green J, Whiteley C, Maden A. Persistence of drug use during imprisonment: Relationship of drug type, recency of use and severity of dependence to use of heroin, cocaine and amphetamine in prison. Addiction 2006; 101(8)1125–1132
   PubMed Web of Science ®Google Scholar
• Strathdee SA, Patrick DM, Currie SL, Cornelisse PG, Rekart ML, Montaner JS, Schechter MT, O'Shaughnessy MV. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS 1997; 11(8)F59–65
   PubMed Web of Science ®Google Scholar
• Sullivan S. Project Civil City. City of Vancouver, VancouverCanada 2006
   Google Scholar
• Tyndall MW, Craib KJ, Currie S, Li K, O'Shaughnessy MV, Schechter MT. Impact of HIV infection on mortality in a cohort of injection drug users. Journal of Acquired Immune Deficiency Syndrome 2001; 28(4)351–357
   PubMed Web of Science ®Google Scholar
• Tyndall MW, Kerr T, Zhang R, King E, Montaner JG, Wood E. Attendance, drug use patterns, and referrals made from North America's first supervised injection facility. Drug and Alcohol Dependence 2006; 83(3)193–198
   PubMed Web of Science ®Google Scholar
• van Beek I. The Sydney Medically Supervised Injecting Centre: The First Five Years. Sydney Medically Supervised Injecting Centre, SyndeyAustralia 2006
   Google Scholar
• Wall R, Rehm J, Fischer B, Brands B, Gliksman L, Stewart J, Medved W, Blake J. Social costs of untreated opioid dependence. Journal of Urban Health 2000; 77(4)688–722
   PubMed Web of Science ®Google Scholar
• Weild AR, Gill ON, Bennett D, Livingstone SJ, Parry JV, Curran L. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: A national survey. Communicable Disease and Public Health 2000; 3(2)121–126
   PubMedGoogle Scholar
• Wente M. This quick fix won't work. The Globe and Mail, November 19, 2002 2002
   Google Scholar
• Wood E, Kerr T, Montaner JS, Strathdee SA, Wodak A, Hankins CA, Schechter MT, Tyndall MW. Rationale for evaluating North America's first medically supervised safer-injecting facility. The Lancet Infectious Diseases 2004; 4(5)301–306
   PubMed Web of Science ®Google Scholar
• Wood E, Kerr T, Small W, Jones J, Schechter MT, Tyndall MW. The impact of a police presence on access to needle exchange programs. Journal of Acquired Immune Deficiency Syndrome 2003; 34(1)116–118
   PubMed Web of Science ®Google Scholar
• Wood E, Kerr T, Small W, Li K, Marsh DC, Montaner JS, Tyndall MW. Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users. Canadian Medical Association Journal 2004; 171(7)731–734
   PubMed Web of Science ®Google Scholar
• Wood E, Kerr TH, Lloyd-Smith E, Buchner C, Marsh DC, Montaner JS, Tyndall MW. Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users. Harm Reduction Journal 2004; 1(1)9
   PubMedGoogle Scholar
• Wood E, Tyndall MW, Montaner JS, Kerr T. Summary of findings from the evaluation of a pilot medically supervised safer injecting facility. Canadian Medical Association Journal 2006; 175(11)1399–1404
   PubMed Web of Science ®Google Scholar